ARTICLE | Clinical News
LY334370: Discontinued Development
March 22, 1999 8:00 AM UTC
Synaptic Pharmaceutical Corp. (SNAP), Paramus, N.J. Product: LY334370 Business: Neurological Therapeutic category: Neurotransmission Target: Serotonin 1F (5HT1F) receptor Description: Selective 5HT1F ...